함께 비교하는 진짜 ADC · Antibody · CGT 데이터

AntibodystaleNovartisPhase 3

Experimental : Secukinumab low dose (Experimental : Secukinumab low dose)

Chronic Severe Plaque-type Psoriasis · Chronic Severe Plaque-type Psoriasis

#ChronicSeverePlaque-typePsoriasi#Antibody#Phase3#항체#면역항체+2

AntibodystaleNovartisPhase 3

Experimental: Secukinumab high dose (Experimental: Secukinumab high dose)

Chronic Severe Plaque-type Psoriasis · Chronic Severe Plaque-type Psoriasis

#ChronicSeverePlaque-typePsoriasi#Antibody#Phase3#항체#면역항체+2

AntibodystaleAmgenPhase 2

Bemarituzumab (Bemarituzumab)

Adenocarcinoma · Gastric Cancer

#GastricCancer#Antibody#Phase2#항체#면역항체+3

효능 ORR 46.8%임상시험 2상태 ACTIVE

AntibodystaleBristol Myers SquibbPhase 3

nivolumab (Opdivo, Nivolumab/rHuPH20)

Melanoma · Melanoma

#Melanoma#Antibody#Phase3#항체#면역항체+2

효능 ORR 0%임상시험 2상태 DISCONTINUED

AntibodystaleNovartis PharmaceuticalsPreclinical

Secikinumab (Secikinumab)

Axial Spondylarthritis (axSpA); Secukinumab · Psoriasis

#Psoriasis#Antibody#Preclinical#항체#면역항체+4

AntibodystaleXencor, Inc.Phase 1

XmAb541 (XmAb541)

Ovarian Cancer · Ovarian Cancer

#OvarianCancer#Antibody#Phase1#항체#면역항체+2

CGTBiologicstaleHan weidongPhase 2

Decitabine-primed Tandem CAR19/20 engineered T cells (Decitabine-primed Tandem CAR19/20 engineered T cells)

Refractory or Relapsed Aggressive r/r B-NHL With Huge Tumor Burden · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4

ADCBiologicstaleEli Lilly and CompanyPhase 3

Sofetabart Mipitecan (Sofetabart Mipitecan)

Ovarian Neoplasms; Fallopian Tube Neoplasms · Ovarian Neoplasms

#OvarianNeoplasms#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2

ADCBiologicstaleGlaxoSmithKlinePhase 1

Ris-Rez (Ris-Rez)

Neoplasms · Neoplasms, Lung

#NeoplasmsLung#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2

CGTBiologicstaleJanssen Research & Development,…Phase 2

Cell therapy with bispecific antibodies (Cell therapy with bispecific antibodies)

Gynecological Solid Tumors · Gynecological Solid Tumors

#GynecologicalSolidTumors#CGT#Phase2#세포유전치료#CAR-T+2

AntibodystaleRochePhase 2

Rituximab/Gemcitabine/Oxaliplatin (Rituximab/Gemcitabine/Oxaliplatin)

Refractory Aggressive Non-Hodgkin's Lymphoma; Relapsing Aggressive Non-Hodgkin's Lymphoma · Combination Therapy

#CombinationTherapy#Antibody#Phase2#항체#면역항체+4

효능 ORR 69.7%임상시험 2상태 RECRUITING

AntibodystalePfizerPhase 2

Elranatamab-bcmm (Elranatamab-bcmm)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase2#항체#면역항체+2

AntibodystaleMacroGenicsPhase 3

Enoblituzumab (Enoblituzumab)

Head and Neck Cancer; Squamous Cell Carcinoma of Head and Neck · Head and Neck Cancer

#HeadandNeckCancer#Antibody#Phase3#항체#면역항체+3

효능 ORR 6%임상시험 2상태 DISCONTINUED

ADCBiologicstaleSeagen Inc.Phase 1

SGN-75 (SGN-75)

Renal Cell Carcinoma · Carcinoma, Renal Cell

#CarcinomaRenalCell#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2

AntibodystaleMacroGenicsPhase 3

Tebotelimab (Tebotelimab)

Gastric Cancer; Gastroesophageal Junction Cancer · Head and Neck Cancer

#HeadandNeckCancer#Antibody#Phase3#항체#면역항체+4

효능 ORR 62.5%임상시험 2상태 DISCONTINUED

AntibodystaleGenmabPhase 2

Acasunlimab (Acasunlimab)

Non Small Cell Lung Cancer Metastatic · Non Small Cell Lung Cancer Metastatic

#NonSmallCellLungCancerMetastatic#Antibody#Phase2#항체#면역항체+2

AntibodystaleXencor, Inc.Phase 2

XmAb18087 (XmAb18087)

Merkel Cell Carcinoma; Small Cell Lung Cancer · Merkel Cell Carcinoma

#MerkelCellCarcinoma#Antibody#Phase2#항체#면역항체+3

AntibodystaleNeovii BiotechPhase 2

ertumaxomab (ertumaxomab)

Metastatic Breast Cancer; Advanced Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#Antibody#Phase2#항체#면역항체+3

AntibodystaleInnoventPhase 2

disitamab vedotin (Disitamab Vedotin, RC48, RC48 combined with Sintilimab and XELOX)

Gastric Cancer · Gastric Cancer

#GastricCancer#Antibody#Phase2#항체#면역항체+2

AntibodystaleAmgenPhase 1

acapatamab (acapatamab)

Metastatic Castration-resistant Prostate Cancer; Prostate Cancer · Metastatic Castration-resistant Prostate

#MetastaticCastration-resistantPr#Antibody#Phase1#항체#면역항체+3

CGTBiologicstaleGyala TherapeuticsPhase 1

CD84-CART (CD84-CART)

Relapsed/Refractory Acute Myeloid Leukemia(AML) · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+4

CGTBiologicstaleYake Biotechnology Ltd.Phase 2

BCMA CAR-T cells (BCMA CAR-T cells)

Multiple Myeloma; New Diagnosis Tumor · BCMA

#BCMA#CGT#Phase2#세포유전치료#CAR-T+4

ADCBiologicstaleAstraZenecaPhase 1

FPI-2053 (FPI-2053)

Advanced Solid Tumor; Metastatic Colorectal Carcinoma · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2

CGTBiologicstaleNational Heart, Lung, and Blood…Phase 2

ATLCAR.CD30 cells (ATLCAR.CD30 cells)

Lymphoma; Lymphoma, Non-Hodgkin · CD30

#CD30#CGT#Phase2#세포유전치료#CAR-T+4